UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934


Date of Report (Date of earliest event reported)               April 6, 2009
                                                 -------------------------------


                               AVOCENT CORPORATION
--------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)


       DELAWARE                      000-30575                91-2032368
--------------------------------------------------------------------------------
 (State or other jurisdiction       (Commission             (IRS Employer
     of incorporation)              File Number)          Identification No.)


4991 CORPORATE DRIVE                               HUNTSVILLE, AL          35805
--------------------------------------------------------------------------------
 (Address of principal executive offices)                       (Zip Code)

Registrant's telephone number, including area code     (256) 430-4000
                                                   -----------------------------

                                       n/a
--------------------------------------------------------------------------------
         (Former name or former address, if changed since last report.)


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

[] Written communications pursuant to Rule 425 under the Securities Act
    (17 CFR 230.425)

[] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
    (17 CFR 240.14a-12)

[] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
   Act (17 CFR 240.14d-2(b))

[] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
   Act (17 CFR 240.13e-4(c))






Item 7.01  Regulation FD Disclosure.

         On April 6, 2009, Avocent Corporation held a conference call discussing
its current revenue estimate for the first quarter of 2009. The prepared remarks
from that conference call are incorporated herein by reference and furnished as
Exhibit 99.5 hereto.

Item 9.01  Financial Statements and Exhibits.

(d)      Exhibits.

         Exhibit Number             Description of Exhibit
         --------------             ----------------------
         99.5                       Prepared Remarks from April 6, 2009
                                    Conference Call







                                   SIGNATURES
                                   ----------

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                                 AVOCENT CORPORATION

Date:  April 6, 2009
                                            By: /s/ Edward H. Blankenship
                                                --------------------------------
                                                Edward H. Blankenship
                                                Senior Vice President of Finance
                                                and Chief Financial Officer








                                 EXHIBIT INDEX
                                 -------------


Exhibit                    Description
-------                    -----------
99.5                       Prepared Remarks for April 6, 2009 Conference Call